Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer

NCT00126555 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

NIH

Sponsor class

Conditions

Recurrent Skin Cancer
Squamous Cell Carcinoma of the Skin

Interventions

DRUG: Gefitinib
RADIATION: Radiotherapy
PROCEDURE: Conventional surgery
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)